Catalent Pharma(@CatalentPharma) 's Twitter Profileg
Catalent Pharma

@CatalentPharma

From drug and biologic development services to delivery technologies to supply solutions. Catalent. More products. Better treatments. Reliably supplied.™

ID:120578352

linkhttp://www.catalent.com calendar_today06-03-2010 22:04:29

10,7K Tweets

19,5K Followers

512 Following

Follow People
Catalent Pharma(@CatalentPharma) 's Twitter Profile Photo

Before transitioning your presentation from a vial to a pre-filled syringe, it's important to understand how formulation development affects the manufacturing of your biologic. Download this article to learn more. ow.ly/g4sE50RsMlO

account_circle
Catalent Pharma(@CatalentPharma) 's Twitter Profile Photo

Hear experts discuss the latest trends in oral solid dosage form manufacturing and how to seamlessly transition your program from early phase to late phase as well as tech transfer. ow.ly/esBO50RzG9l

account_circle
Catalent Pharma(@CatalentPharma) 's Twitter Profile Photo

Catalent is delighted to announce our strategic partnership with Siren Biotechnology, Inc. to support the development and manufacturing of their immuno-gene therapies. Read the full press release here: ow.ly/Qy3B50RzzoY

account_circle
Catalent Pharma(@CatalentPharma) 's Twitter Profile Photo

Join at the ISCT 2024 Annual Meeting in Vancouver, Canada, booth 508. A premier gathering of experts in cell and gene therapy, featuring Catalent's innovative showcase & top-notch speakers like Boris Greber, Daniel Terheyden-Keighley & Rupa Pike. ow.ly/94r050RyYtf

account_circle
Catalent Pharma(@CatalentPharma) 's Twitter Profile Photo

Introducing Catalent Xpress Pharmaceutics®: Formulation development with on-demand clinical manufacturing, regulatory support, and clinical testing for efficient First-in-Human studies. Fast-track to Phase 1 in 4-6 months! ow.ly/fteH50RyKZU

Introducing Catalent Xpress Pharmaceutics®: Formulation development with on-demand clinical manufacturing, regulatory support, and clinical testing for efficient First-in-Human studies. Fast-track to Phase 1 in 4-6 months! #AdaptiveTrials #DrugDevelopment ow.ly/fteH50RyKZU
account_circle
Catalent Pharma(@CatalentPharma) 's Twitter Profile Photo

Catalent’s Uptempoˢᵐ Antibody platform combines the industry-leading GPEx® cell line development technology with streamlined, phase-appropriate drug development to deliver products from early-stage development through CGMP manufacturing. Register today! ow.ly/3OnK50Rve3X

account_circle
Catalent Pharma(@CatalentPharma) 's Twitter Profile Photo

Schedule a meeting with our team at AAPS in San Francisco to discuss how Catalent Biologics can help accelerate your proteins, cell and gene therapies, and vaccines with a wide range of reliable GMP analytical services. ow.ly/E9Bz50RxVlA

Schedule a meeting with our team at AAPS in San Francisco to discuss how Catalent Biologics can help accelerate your proteins, cell and gene therapies, and vaccines with a wide range of reliable GMP analytical services. ow.ly/E9Bz50RxVlA
account_circle
Catalent Pharma(@CatalentPharma) 's Twitter Profile Photo

Join us for ARM's 1.5-day workshop on Advanced Manufacturing in CGT, May 16-17, 2024, in Rockville, MD! Explore emerging technologies & innovations with Junxia Wang of Catalent. Don't miss it. Register now: ow.ly/Vgqc50RjrCo

Join us for ARM's 1.5-day workshop on Advanced Manufacturing in CGT, May 16-17, 2024, in Rockville, MD! Explore emerging technologies & innovations with Junxia Wang of Catalent. Don't miss it. Register now: ow.ly/Vgqc50RjrCo #ARMWorkshop #CGT #AdvancedManufacturing
account_circle
Catalent Pharma(@CatalentPharma) 's Twitter Profile Photo

Schedule a meeting with our experts. Learn all about our integrated solutions for cell & gene therapies from raw material supply to clinic and commercial-scale manufacturing, plasmids, viral vectors, iPSCs, & autologous & allogeneic therapies. ow.ly/UUCp50RxeL1

account_circle
Catalent Pharma(@CatalentPharma) 's Twitter Profile Photo

Come and meet our team at booth #8, on May 15 & 16 during Knowledge for Growth in Antwerp, Belgium, to learn more about our comprehensive solutions from development to finished product supply and how we can help you deliver biologic therapies to patients. ow.ly/TzGW50Rv7RA

account_circle
Catalent Pharma(@CatalentPharma) 's Twitter Profile Photo

Discover how a deep understanding of process characterization can drive successful clinical phases and accelerate commercial launch of biological drug development. Catalent Biologics experts share their insights here. ow.ly/oOT150RsZqU

account_circle
Catalent Pharma(@CatalentPharma) 's Twitter Profile Photo

Streamline your vector development journey with Catalent's advanced tools and a pre-qualified analytical suite, ensuring high-yield, high-quality vectors without compromising on speed. Add Carey Connelly’s symposium to your schedule at ! ow.ly/K9Ly50RwkeX

Streamline your vector development journey with Catalent's advanced tools and a pre-qualified analytical suite, ensuring high-yield, high-quality vectors without compromising on speed. Add Carey Connelly’s symposium to your schedule at #ASGCT2024! ow.ly/K9Ly50RwkeX
account_circle
Catalent Pharma(@CatalentPharma) 's Twitter Profile Photo

Learn why consumer health brands rely on Catalent to scale-up quickly and bring new products to market. Industry leading and experienced , reliability supplied, something to chew on. ow.ly/X1gN50RwhVw

account_circle
Catalent Pharma(@CatalentPharma) 's Twitter Profile Photo

Join this upcoming event in Munich, where industry experts will discuss drug development challenges and offer solutions for improving bioavailability, optimizing manufacturing, and accelerating progression to the clinic. Register today! ow.ly/32AP50Rwfns

account_circle
Catalent Pharma(@CatalentPharma) 's Twitter Profile Photo

Join us at the Extractables and Leachables USA 2024 as Catalent expert Dr. Vicki Ward shares a case study illustrating how a systematic E&L manufacturing risk assessment approach can support drug sponsors in obtaining regulatory approval. Learn more here! ow.ly/3eum50RweAM

Join us at the Extractables and Leachables USA 2024 as Catalent expert Dr. Vicki Ward shares a case study illustrating how a systematic E&L manufacturing risk assessment approach can support drug sponsors in obtaining regulatory approval. Learn more here! ow.ly/3eum50RweAM
account_circle
Catalent Pharma(@CatalentPharma) 's Twitter Profile Photo

Catalent’s Uptempoˢᵐ Antibody platform combines the industry-leading GPEx® cell line development technology with streamlined, phase-appropriate drug development to deliver products from early-stage development through CGMP manufacturing. Register today! ow.ly/3OnK50Rve3X

account_circle
Catalent Pharma(@CatalentPharma) 's Twitter Profile Photo

Accelerate growth in your supplement business with innovative, experiential dose forms. Visit Booth to partner with Catalent, an industry-leading developer and manufacturer of vitamins, supplements, OTC medications, and topical beauty products. catalent.com/events/vitafoo…

account_circle
Catalent Pharma(@CatalentPharma) 's Twitter Profile Photo

Come and meet our team at booth #8, on May 15 & 16 during Knowledge for Growth in Antwerp, Belgium, to learn more about our comprehensive solutions from development to finished product supply and how we can help you deliver biologic therapies to patients. ow.ly/TzGW50Rv7RA

account_circle
Catalent Pharma(@CatalentPharma) 's Twitter Profile Photo

JunXia Wang will present at on Catalent's new UpTempo℠ CAR-T Platform Process. This fully closed and GMP-compliant platform for the manufacturing of CAR-T cell therapies is a modular, plug-and-play model. Learn more here: ow.ly/hoSb50RuGQw

JunXia Wang will present at #ASGCT2024 on Catalent's new UpTempo℠ CAR-T Platform Process. This fully closed and GMP-compliant platform for the manufacturing of CAR-T cell therapies is a modular, plug-and-play model. Learn more here: ow.ly/hoSb50RuGQw
account_circle
Catalent Pharma(@CatalentPharma) 's Twitter Profile Photo

Explore Catalent’s Schorndorf manufacturing site for complex controlled release oral solid dose forms including integrated development, commercial manufacture and packaging capabilities. ow.ly/EgMf50RtZhc

Explore Catalent’s Schorndorf manufacturing site for complex controlled release oral solid dose forms including integrated development, commercial manufacture and packaging capabilities. ow.ly/EgMf50RtZhc
account_circle